Precigen (PGEN) Equity Income (2013 - 2014)
Precigen's (PGEN) quarterly Equity Income came in at -$9.7 million in Q1 2014, down 510.75% year-on-year from $2.4 million in Q1 2013, and down 510.75% on a QoQ basis from -$1.6 million in Q1 2013.
Precigen (PGEN) Equity Income (2013 - 2014) Analysis & Trends
Precigen (PGEN) has 2 years of Equity Income data on file, last reported at -$9.7 million in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | -9.71 Mn |
| Mar 31, 2013 | -1.59 Mn |